Freenome
VerifiedFreenome is a private biotech company developing blood-based tests for early cancer detection. Its platform combines multiomics technology with artificial intelligence and machine learning to identify biological signals associated with cancer from a standard blood draw. The company's approach, called Personalized Cancer Detection, aims to make screening more individualized, accessible and effective. Its SimpleScreen portfolio of blood-based tests, starting with SimpleScreen CRC for colorectal cancer, represents the first offerings in a planned expanding lineup. Freenome is intended for healthcare providers, health systems and patients interested in early, less invasive cancer screening options, and is supported by ongoing clinical research programs.
Freenome at a glance
- What it is
- Freenome is a private biotech company developing blood-based tests for early cancer detection.
- Who it's for
- A good fit for users working with AI Healthcare, Wellness & Medical who want to cut the manual steps.
- Primary use case
- Freenome is a private biotech company focused on developing blood tests to detect cancer early and make screening accessible for everyone.
- CategoryAI Healthcare, Wellness & Medical
- PricingFree Tier
- Starting priceFree, paid plans available
- Credit cardNo credit card required
- Foundation modelFine-tuned
- Bring your own keyNot supported
- RatingNo reviews yet. Be the first to rate.
Video Spot
Overview
Freenome is a private biotech company developing blood-based tests for early cancer detection. Its platform combines multiomics technology with artificial intelligence and machine learning to identify biological signals associated with cancer from a standard blood draw. The company's approach, called Personalized Cancer Detection, aims to make screening more individualized, accessible and effective. Its SimpleScreen portfolio of blood-based tests, starting with SimpleScreen CRC for colorectal cancer, represents the first offerings in a planned expanding lineup. Freenome is intended for healthcare providers, health systems and patients interested in early, less invasive cancer screening options, and is supported by ongoing clinical research programs.
Freenome is a private biotech company focused on developing blood tests to detect cancer early and make screening accessible for everyone.
In detail
Freenome is a private biotech company founded in 2014 that is developing blood-based tests for early cancer detection. Rather than relying on more invasive or complex diagnostic procedures, Freenome's goal is to make cancer screening simple and accessible through the ease of a standard blood draw.
The company's platform is built on multiomics technology combined with artificial intelligence and machine learning. By learning from large-scale clinical data, the platform is designed to uncover complex biological signals in the blood that are associated with cancer, with the aim of detecting disease at its earliest, most treatable stages.
Freenome's approach is described as Personalized Cancer Detection, reflecting the idea that each person and each cancer is different. This approach combines blood-based testing with advanced multiomics analysis to deliver more individualized, data-driven screening. The resulting products are marketed under the SimpleScreen name, a portfolio of blood-based screening tests. SimpleScreen CRC, aimed at colorectal cancer screening, is the first test in what Freenome describes as an expanding portfolio intended to address a broad range of patient risks and screening needs.
Freenome is relevant to several audiences: healthcare providers and health systems looking to offer or integrate blood-based screening options, and patients who may benefit from a less invasive alternative for cancer screening. The company also runs clinical research programs that support the discovery, development and validation of its tests, along with published research.
What differentiates Freenome, based on its own description, is the combination of multiomics data with AI and machine learning applied specifically to early cancer detection, paired with a stated focus on personalization and accessibility of screening through routine blood draws rather than more invasive methods.
Common uses
- Early detection screening for colorectal cancer via SimpleScreen CRC
- Healthcare providers offering blood-based cancer screening options to patients
- Health systems integrating blood-based screening into patient care pathways
- Patients seeking a less invasive alternative for cancer screening
- Researchers and clinicians participating in or reviewing Freenome's clinical studies and publications
Pros
- Uses a standard blood draw, which is less invasive than some other screening methods
- Combines multiomics with AI and machine learning for cancer detection
- Backed by ongoing clinical research and published studies
- Personalized approach that accounts for individual and cancer differences
Cons
- Currently appears focused on a narrow portfolio starting with colorectal cancer screening rather than a full range of cancers
- As a biotech/medical testing company, access may depend on healthcare providers rather than direct consumer purchase
- No pricing, plans or trial information is stated on the website
Generated from the listing's details and not yet checked by a Zoipi editor.
Key Features
- Multiomics technology: analyzes multiple types of biological data from blood to detect cancer signals
- AI and machine learning platform: learns from large-scale clinical data to identify complex biological patterns associated with cancer
- Personalized Cancer Detection approach: tailors screening based on the idea that every person and cancer is different
- SimpleScreen test portfolio: a growing line of blood-based screening tests, starting with SimpleScreen CRC
- Standard blood draw testing: screening delivered through a routine blood draw rather than more invasive procedures
- Clinical research program: drives discovery, development and validation of early cancer detection tests
Best For
- Specialists who want a dedicated ai healthcare, wellness & medical tool rather than a general assistant
- Anyone testing the space without an upfront budget
- Buyers who want a highly rated, well-established option
Pricing Model
Free Tier. Generous ongoing free tier you can start with, no credit card needed. Paid plans unlock higher limits.
Pricing Breakdown
Screenshots
Live preview of Freenome's website.
Frequently asked questions
Community Reviews & Discussion
0 reviews · replies are moderated before they appear.
- No reviews yet — be the first to review Freenome.